Below is a list of news items that were submitted to the news feed:
Featured Article
|
Below is a list of news items that were submitted to the news feed: Featured Article |
|
1-10 (8/7/10 - 9/5/10) 11-20 (5/15/10 - 8/5/10) 21-30 (4/4/10 - 5/14/10) 31-40 (3/12/10 - 3/31/10) 41-50 (3/1/10 - 3/12/10) 51-60 (2/4/10 - 2/17/10) 61-70 (1/13/10 - 2/3/10) 71-80 (12/26/09 - 1/11/10) 81-90 (11/17/09 - 12/23/09) 91-100 (10/11/09 - 11/16/09) 101-110 (9/28/09 - 10/10/09) 111-120 (8/25/09 - 9/20/09) 121-130 (7/5/09 - 8/24/09) 131-140 (6/3/09 - 6/27/09) 141-150 (4/21/09 - 5/18/09) 151-160 (4/3/09 - 4/20/09) 161-170 (3/20/09 - 4/2/09) 171-180 (2/19/09 - 3/14/09) 181-190 (2/6/09 - 2/18/09) 191-200 (1/9/09 - 2/3/09) 201-210 (12/26/08 - 1/8/09) 211-220 (12/13/08 - 12/26/08) 221-230 (11/26/08 - 12/12/08) 231-240 (11/18/08 - 11/25/08) 241-250 (10/24/08 - 11/17/08) 251-260 (10/2/08 - 10/22/08) 261-270 (9/15/08 - 10/2/08) 271-280 (8/28/08 - 9/12/08) 281-290 (7/23/08 - 8/27/08) 291-300 (6/23/08 - 7/19/08) 301-310 (6/6/08 - 6/20/08) 311-320 (4/22/08 - 6/6/08) 321-330 (3/17/08 - 4/21/08) 331-340 (2/22/08 - 3/11/08) 341-350 (2/15/08 - 2/22/08) 351-360 (1/30/08 - 2/15/08) 361-370 (1/17/08 - 1/29/08) 371-380 (1/5/08 - 1/17/08) 381-390 (12/11/07 - 1/3/08) 391-400 (11/27/07 - 12/9/07) 401-410 (10/20/07 - 11/26/07) 411-420 (10/3/07 - 10/19/07) 421-430 (9/8/07 - 10/2/07) 431-440 (8/21/07 - 9/7/07) 441-450 (8/1/07 - 8/20/07) 451-460 (7/11/07 - 7/30/07) 461-470 (6/22/07 - 7/8/07) 471-480 (6/3/07 - 6/21/07) 481-490 (5/15/07 - 6/1/07) 491-500 (4/29/07 - 5/14/07) 501-510 (4/11/07 - 4/27/07) 511-520 (4/2/07 - 4/11/07) 521-530 (3/19/07 - 4/2/07) 531-540 (2/22/07 - 3/19/07) 541-550 (2/13/07 - 2/21/07) 551-560 (2/1/07 - 2/12/07) 561-570 (12/12/06 - 2/1/07) 571-580 (9/9/06 - 12/12/06) 581-590 (6/24/06 - 8/31/06) 591-600 (5/4/06 - 6/22/06) 601-610 (2/17/06 - 5/2/06) 611-620 (1/7/06 - 2/17/06) 621-630 (12/8/05 - 1/6/06) 631-640 (11/27/05 - 12/7/05) 641-650 (11/12/05 - 11/26/05) 651-660 (10/12/05 - 11/8/05) 661-670 (9/20/05 - 10/11/05) 671-680 (8/30/05 - 9/16/05) 681-690 (8/10/05 - 8/29/05) 691-700 (7/13/05 - 8/10/05) 701-710 (6/8/05 - 7/12/05) 711-720 (5/18/05 - 6/2/05) 721-730 (4/19/05 - 5/12/05) 731-740 (4/4/05 - 4/18/05) 741-750 (3/8/05 - 3/31/05) 751-760 (2/23/05 - 3/7/05) 761-770 (2/6/05 - 2/22/05) 771-780 (1/20/05 - 2/6/05) 781-790 (1/3/05 - 1/19/05) 791-800 (11/29/04 - 12/28/04) 801-810 (10/24/04 - 11/28/04) 811-820 (9/20/04 - 10/21/04) 821-830 (8/16/04 - 9/19/04) 831-840 (7/26/04 - 8/5/04) 841-850 (6/30/04 - 7/23/04) 851-860 (6/11/04 - 6/30/04) 861-870 (5/10/04 - 6/11/04) 871-880 (4/30/04 - 5/10/04) 881-890 (4/18/04 - 4/29/04) 891-900 (2/25/04 - 4/14/04) 901-910 (10/28/03 - 2/19/04) 911-920 (9/30/03 - 10/28/03) 921-930 (7/14/03 - 9/27/03) 931-940 (5/7/03 - 7/14/03) 941-950 (4/15/03 - 5/6/03) 951-960 (2/14/03 - 4/13/03) 961-970 (1/20/03 - 2/12/03) 971-980 (1/6/03 - 1/17/03) 981-990 (10/16/02 - 12/25/02) 991-1000 (9/19/02 - 10/16/02) 1001-1001 (0/0/ - 0/0/) |
|
831. HHS Announces Initiative to Reduce the Incidence of Stroke in ... http://releases.usnewswire.com/GetRelease.asp?id=111-08052004 2004-08-05 12:13:16 Description: WASHINGTON, Aug. 5 /U.S. Newswire/ -- HHS Secretary Tommy G. Thompson today announced approximately $2 million in grant awards to support a new initiative aimed at reducing the excessively high rates of stroke, stroke disabilities and stroke deaths that disproportionately occur in the southeastern region of the United States. The Secretary's Stroke Belt Elimination Initiative (SBEI) awards approximately $8 million over four years within the seven states experiencing the highest stroke death rates. The three grant recipients are: Forsyth Medical Center Foundation, Winston- Salem, N.C; Medical University of South Carolina, Charleston, S.C.; and the University of Alabama at Birmingham, Birmingham, Ala. These institutions along with local community-based organizations will implement and coordinate prevention and awareness programs locally and across the region targeting stroke and hypertension. |
|
832. New Therapy Speeds Stroke Recovery http://www.healthcentral.com/news/NewsFullText.cfm?id=520372 2004-08-04 12:13:08 Description: WEDNESDAY, Aug. 4 (HealthDayNews) -- Injection of immune cells into the brains of stroke-damaged mice encouraged nerve regrowth and repair, says a Japanese study in the Aug. 2 issue of the Journal of Clinical Investigation. The scientists collected CD34+ immune cells from human umbilical cord blood and injected those cells into mice within 48 hours of an induced stroke. The mice that received these cells showed an increase in new blood vessel and nerve growth in the damaged regions. |
|
833. Fear of strokes leads to cold medicine ban http://joongangdaily.joins.com/200408/01/200408012329187939900090409041.html 2004-08-01 12:12:34 Description: Fear of strokes leads to cold medicine ban The Korea Food and Drug Administration yesterday banned the sale, distribution and manufacture of all cold medicines containing phenylpropanolamine, or PPA, saying the ingredient raised the chances of hemorrhagic stroke. The cold medicines ¡ª 167 of them produced or imported by 75 companies ¡ª are subject to the ban. These include Contac 600 manufactured by Yuhan Corp. and Facol-F produced by Choongwae Pharmaceutical. The administration said that it had identified a causal association between PPA and hemorrhagic stroke. The agency said persons with high blood pressure who take PPA long term may be at greater risk. The drug agency ordered the pharmaceutical companies to recall and destroy all the products as soon as possible and report the results of the recall and disposal by Sept. 30. The drug agency also urged all drug stores and hospitals not to sell, prescribe or use the medicines. "We found out that the probability of hemorrhagic stroke for PPA takers was twice as high as for non-PPA takers," said Yoon Byung-woo, a professor in Seoul National University's Department of Neurology. Dr. Yoon headed a research team that was formed to conduct research on whether there were any health risks associated with PPA. |
|
834. Stroke victims could be helped with foetal brain cells http://www.medicalnewstoday.com/medicalnews.php?newsid=11510 2004-08-01 09:17:11 Description: Stroke victims could have some of their dead brain cells replaced with brain cells taken from foetuses, say scientists. Scientists in the USA implanted foetal brain cells into rats that had had a stroke and saw that these foetal brain cells went into the damaged area of the brain and survived. This could help stroke victims whose dead brain cells often cause nearby cells to die as well. This study was carried out at Stanford University, California, USA. Study leader Gary Steinberg, said “It’s the first time it’s been shown that such a human cell can survive, migrate and differentiate in a stroke environment, which is not the most favourable environment.” The brain cells had been taken from aborted foetuses many years ago. They had been developing in the labs of StemCells Inc, Palo Alto, California. Steinberg explained that these brain cells are not embryonic stem cells. He said they are taken from a line established many years ago and should not be as controversial (regarding human embryos). |
|
835. Sleeping Disorder Linked to Risk of Stroke Death http://paktribune.com/news/index.php?id=72154 2004-07-27 15:13:32 Description: ISLAMABAD, July 28 (Online): A sleep-related disorder that causes repeated interruptions in breathing is a new risk factor for death from stroke, Spanish researchers said Tuesday. Sleep apnea affects about 20 percent of people. Sufferers can stop breathing for 10 seconds or more while asleep, sometimes more than 300 times a night. Dr Olga Parra and researchers at Barcelona University Hospital in Spain monitored 161 stroke patients and found that their risk of dying from a stroke was linked to sleep apnea. "It's the first time the link between apnea and stroke has been shown to affect mortality," Parra said. |
|
836. Foetal brain cells show hope for stroke victims: study http://www.abc.net.au/news/newsitems/200407/s1163295.htm 2004-07-27 09:18:40 Description: Brain cells taken from foetuses may be able to replace some of those killed in a stroke, United States researchers have reported. Implanting the brain cells in rats showed that the immature brain cells found their way to the area of stroke damage and stayed alive - an important feat, because the damage caused by stroke often kills off neighbouring cells, too. The cells may also offer a way to treat devastating brain diseases and spinal cord injuries, the team at Stanford University in California said. "It's the first time it's been shown that such a human cell can survive, migrate and differentiate in a stroke environment, which is not the most favourable environment," said neurosurgeon Gary Steinberg, who led the study. Dr Steinberg's team used cells that were originally taken for aborted foetuses years ago and that have been growing in laboratories run by Palo Alto-based StemCells Incorporated. The brain cells "are not embryonic stem cells," Dr Steinberg said, referring to controversial cells taken from days-old human embryos. "They are from a line established many years ago and should not be as controversial." Stem cells are immature cells that have the potential to give rise to any number of different kinds of cells and tissues. There are various sources, from the bone marrow to foetal tissue to embryos. Controversy Use of embryonic cells results in controversy, because of philosophical differences over the nature and beginning of life. Dr Steinberg's team tested the foetal brain cells in rats given an artificial stroke. Writing in the Proceedings of the National Academies of Science, they said the cells lived for as long as a month in the rats and also found their way to the site of the stroke. "These are smart cells," Dr Steinberg said. "Why do these cells migrate towards the stroke? We think and have some preliminary evidence that it is due to chemicals or chemokines being released in the stroke area." Chemokines are chemical signals released by cells - a kind of molecular call for help in this case. Now his team is evaluating the rats to see if the cells did them any good. Stroke can cause paralysis, loss of language and other problems in people. Dr Steinberg said it is not yet clear whether immune-suppressing drugs such as cyclosporin would have to be used to prevent the body from rejecting the cells. The rats were given the drug. Next Dr Steinberg says his team plans to use the cells in human experimental trials for a "devastating brain disease", but said he could give no details. -- Reuters Print Email Brain cells taken from foetuses may be able to replace some of those killed in a stroke United States researchers have reported Implanting the brain cells in rats showed that the immature brai |
|
837. Eating fish protects against stroke http://www.heartcenteronline.com/myheartdr/home/research-detail.cfm?reutersid=4560 2004-07-26 18:13:12 Description: Jul 26 (Reuters Health) - More evidence that fish consumption reduces the chances of having a stroke comes from an analysis of results from several large studies. In fact, the findings suggest that "the incidence of ischemic stroke might be significantly reduced by consuming fish as seldom as 1 to 3 times per month," Dr. Ka He, at Northwestern University in Chicago, and associates comment in their report in the medical journal Stroke. |
|
838. CBS News | New Cholesterol Pill Enters Market | July 26, 2004 14:47:24 http://www.cbsnews.com/stories/2004/07/26/health/main631898.shtml CBS News 2004-07-26 15:04:36 Description: Vytorin, the first pill to lower cholesterol in two ways, should hit pharmacy shelves within weeks, the makers said Monday as they promised heavy marketing and a discounted price to battle the top-selling competition. |
|
839. Aspirin Resistance Test Now Available Nationwide http://biz.yahoo.com/prnews/040726/lam064_1.html 2004-07-26 09:21:36 Description: Creative Clinical Concepts, Inc., has announced that its aspirin resistance test is now available nationwide. The new test, called AspirinWorks®, is ideally suited for patients on long-term aspirin therapy and can be ordered by any doctor's office or hospital laboratory in the U.S. |
|
840. Boston Life Sciences Files Investigational New Drug Application ... http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20040726005475& newsLang=en 2004-07-26 09:21:35 Description: Boston Life Sciences, Inc. (NASDAQ: BLSI) announced that the Company has filed an Investigational New Drug (IND) application with the FDA for the use of Axosine(TM) to enhance motor function recovery after stroke. The IND includes a proposed human Phase I study protocol to test the safety of Axosine administered to stroke patients for 28 days by continuous infusion into one of the fluid compartments of the brain (intracerebral ventricle; ICV). Pre-clinical efficacy and safety animal testing has shown that Axosine, when administered in this manner, is safe, well-tolerated, and highly effective in promoting motor function recovery after experimentally-induced strokes in rats. The results of these efficacy studies, as well as studies demonstrating compensatory axon growth in experimental spinal cord injury, have been published in numerous prestigious scientific journals during the last few years. The Company believes that Axosine is the first in a class of small molecule (nonpeptide) axonal growth factors to enter commercial clinical development for this indication. The Company hopes to initiate its Phase I study following a 30 day FDA review of the IND, although the Company cautions that the FDA may have questions or concerns that require a response or additional preclinical studies to be performed prior to initiating the Phase I study. |
|
1-10 (8/7/10 - 9/5/10) 11-20 (5/15/10 - 8/5/10) 21-30 (4/4/10 - 5/14/10) 31-40 (3/12/10 - 3/31/10) 41-50 (3/1/10 - 3/12/10) 51-60 (2/4/10 - 2/17/10) 61-70 (1/13/10 - 2/3/10) 71-80 (12/26/09 - 1/11/10) 81-90 (11/17/09 - 12/23/09) 91-100 (10/11/09 - 11/16/09) 101-110 (9/28/09 - 10/10/09) 111-120 (8/25/09 - 9/20/09) 121-130 (7/5/09 - 8/24/09) 131-140 (6/3/09 - 6/27/09) 141-150 (4/21/09 - 5/18/09) 151-160 (4/3/09 - 4/20/09) 161-170 (3/20/09 - 4/2/09) 171-180 (2/19/09 - 3/14/09) 181-190 (2/6/09 - 2/18/09) 191-200 (1/9/09 - 2/3/09) 201-210 (12/26/08 - 1/8/09) 211-220 (12/13/08 - 12/26/08) 221-230 (11/26/08 - 12/12/08) 231-240 (11/18/08 - 11/25/08) 241-250 (10/24/08 - 11/17/08) 251-260 (10/2/08 - 10/22/08) 261-270 (9/15/08 - 10/2/08) 271-280 (8/28/08 - 9/12/08) 281-290 (7/23/08 - 8/27/08) 291-300 (6/23/08 - 7/19/08) 301-310 (6/6/08 - 6/20/08) 311-320 (4/22/08 - 6/6/08) 321-330 (3/17/08 - 4/21/08) 331-340 (2/22/08 - 3/11/08) 341-350 (2/15/08 - 2/22/08) 351-360 (1/30/08 - 2/15/08) 361-370 (1/17/08 - 1/29/08) 371-380 (1/5/08 - 1/17/08) 381-390 (12/11/07 - 1/3/08) 391-400 (11/27/07 - 12/9/07) 401-410 (10/20/07 - 11/26/07) 411-420 (10/3/07 - 10/19/07) 421-430 (9/8/07 - 10/2/07) 431-440 (8/21/07 - 9/7/07) 441-450 (8/1/07 - 8/20/07) 451-460 (7/11/07 - 7/30/07) 461-470 (6/22/07 - 7/8/07) 471-480 (6/3/07 - 6/21/07) 481-490 (5/15/07 - 6/1/07) 491-500 (4/29/07 - 5/14/07) 501-510 (4/11/07 - 4/27/07) 511-520 (4/2/07 - 4/11/07) 521-530 (3/19/07 - 4/2/07) 531-540 (2/22/07 - 3/19/07) 541-550 (2/13/07 - 2/21/07) 551-560 (2/1/07 - 2/12/07) 561-570 (12/12/06 - 2/1/07) 571-580 (9/9/06 - 12/12/06) 581-590 (6/24/06 - 8/31/06) 591-600 (5/4/06 - 6/22/06) 601-610 (2/17/06 - 5/2/06) 611-620 (1/7/06 - 2/17/06) 621-630 (12/8/05 - 1/6/06) 631-640 (11/27/05 - 12/7/05) 641-650 (11/12/05 - 11/26/05) 651-660 (10/12/05 - 11/8/05) 661-670 (9/20/05 - 10/11/05) 671-680 (8/30/05 - 9/16/05) 681-690 (8/10/05 - 8/29/05) 691-700 (7/13/05 - 8/10/05) 701-710 (6/8/05 - 7/12/05) 711-720 (5/18/05 - 6/2/05) 721-730 (4/19/05 - 5/12/05) 731-740 (4/4/05 - 4/18/05) 741-750 (3/8/05 - 3/31/05) 751-760 (2/23/05 - 3/7/05) 761-770 (2/6/05 - 2/22/05) 771-780 (1/20/05 - 2/6/05) 781-790 (1/3/05 - 1/19/05) 791-800 (11/29/04 - 12/28/04) 801-810 (10/24/04 - 11/28/04) 811-820 (9/20/04 - 10/21/04) 821-830 (8/16/04 - 9/19/04) 831-840 (7/26/04 - 8/5/04) 841-850 (6/30/04 - 7/23/04) 851-860 (6/11/04 - 6/30/04) 861-870 (5/10/04 - 6/11/04) 871-880 (4/30/04 - 5/10/04) 881-890 (4/18/04 - 4/29/04) 891-900 (2/25/04 - 4/14/04) 901-910 (10/28/03 - 2/19/04) 911-920 (9/30/03 - 10/28/03) 921-930 (7/14/03 - 9/27/03) 931-940 (5/7/03 - 7/14/03) 941-950 (4/15/03 - 5/6/03) 951-960 (2/14/03 - 4/13/03) 961-970 (1/20/03 - 2/12/03) 971-980 (1/6/03 - 1/17/03) 981-990 (10/16/02 - 12/25/02) 991-1000 (9/19/02 - 10/16/02) 1001-1001 (0/0/ - 0/0/) |